Predicting left atrial thrombi in atrial fibrillation

American Heart Journal

Volumn 159, Issue 4, 2010, Pages 665-671

  Wysokinski, Waldemar E ^a   Ammash, Naser ^a   Sobande, Folakemi ^a   Kalsi, Henna ^a   Hodge, David ^a   McBane, Robert D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ARTIFICIAL EMBOLISM; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; LEFT ATRIAL APPENDAGE THROMBUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 77950211910     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.043     Document Type: Article

References (41)

1. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 22 (1991) 983-988
2. Lin H.J., Wolf P.A., Kelly-Hayes M., et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 27 (1996) 1760-1764
3. Stroke Prevention in Atrial Fibrillation Investigators. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation study. J Stroke Cerebrovasc Dis 5 (1995) 147-157
4. Hart R.G., and Halperin J.L. Atrial fibrillation and stroke: concepts and controversies. Stroke 32 (2001) 803-808
5. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
6. Albers G.W., Diener H.C., Frison L., et al. SPORTIF Executive Steering Committee for the SPORTIF V Investigators. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA 293 (2005) 690-698
7. Miller V.T., Rothrock J.F., Pearce L.A., et al. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators. Neurology. 43 (1993) 32-36
8. Hart R.G., Pearce L.A., Miller V.T., et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 10 (2000) 39-43
9. van Walraven C., Hart R.G., Singer D.E., et al. Oral anticoagulants vs. aspirin in nonvalvular atrial fibrillation. An individual patient meta-analysis. JAMA 288 (2002) 2441-2448
10. Mohr J., Thompson J.L.P., Lazar R.M., et al. A comparison of warfarin and aspirin for prevention of recurrent ischemic stroke. N Engl J Med 345 (2001) 1444-1451
11. Chimowitz M.I., Lynn M.J., Howlett-Smith H., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352 (2005) 1305-1316
12. Stroke Risk in Atrial Fibrillation Working Group. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 39 (2008) 1901-1910
13. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
14. Fang M.C., Go A.S., Chang Y., et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 5 (2008) 810-815
15. Manning W.J., Weintraub R.M., Waksmonski C.A., et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study. Ann Intern Med 123 (1995) 817-822
16. Habara S., Dote K., Kato M., et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 28 (2007) 2217-2222
17. Jaber W.A., Prior D.L., Thamilarasan M., et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: a transesophageal echocardiographic study. Am Heart 140 (2000) 150-156
18. Seward J.B., Khandheria B.K., Edwards W.D., et al. Biplanar transesophageal echocardiography: anatomic correlations, image orientation, and clinical applications. Mayo Clin Proc 65 (1990) 1193-1213
19. Freeman W.K., Seward J.B., Khandheria B.K., et al. Transesophageal echocardiography (1994), Little, Brown and Company, Boston (Mass)
20. Grimm R.A., Black I.W., and Klein A.L. Transesophageal echocardiography before cardioversion. N Engl J Med 329 (1993) 577-578
21. Goldman M.E., Pearce L.A., Hart R.G., et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage. J Am Soc Echocardiogr 12 (1999) 1080-1087
22. The Echo Manual: Jae K Oh, James B. Seward, A. Jamil Tajik, Third edition, Lippincott Williams and Wilkins; 1994. p. 109-19.
23. Genuth S., Alberti K.G., Bennett P., et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160
24. Gillum R.F., Fortmann S.P., Prineas R.J., et al. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 108 (1984) 150-158
25. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation 114 (2006) e257-e354
26. Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 185 (1969) 373-379
27. Manning W.J., Silverman D.I., Waksmonski C.A., et al. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. Arch Intern Med 155 (1995) 2193-2198
28. Klein A.L., Grimm R.A., Murray R.D., et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344 (2001) 1411-1420
29. Hart R.G., Benavente O., and Pearce L.A. Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovasc Dis 9 (1999) 215-217
30. Hart R.G., Pearce L.A., McBride R., et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke. 30 (1999) 1223-1229
31. Stollberger C., Chnupa P., Kronik G., et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. Ann Int Med 128 (1998) 630-638
32. Fatkin D., Kelly R.P., and Feneley M.P. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23 (1994) 961-969
33. Gurevitz O.T., Varadachari C.J., Ammash N.M., et al. The effect of patient sex on recurrence of atrial fibrillation following successful direct current cardioversion. Am Heart J 152 (2006) 155.e9-155.e13
34. Wang T.J., Massaro J.M., Levy D., et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290 (2003) 1049-1056
35. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 158 (1998) 1316-1322
36. The Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 69 (2007) 546-554
37. Singer D.E., Albers G.W., Dalen J.E., et al. American College of Chest Physicians. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 6 Suppl (2008) 546S-592S
38. Lai S.L., Weng H.H., Lee M., et al. Risk factors and subtype analysis of acute ischemic stroke. Eur Neurol 60 (2008) 230-236
39. Fang M.C., Singer D.E., Chang Y., et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study. Circulation 112 (2005) 1687-1692
40. Wysokinski W.E., Owen W.G., Fass D.N., et al. Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized. J Thromb Haemost 2 (2004) 1637-1644
41. McBane R.D., Hodge D.O., and Wysokinski W.E. Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation. Thromb Haemost 99 (2008) 951-955